SIEMENS HEALTHINEERS AG (1SHL.MI) Stock Fundamental Analysis
Europe - BIT:1SHL - DE000SHL1006 - Common Stock
43.74 EUR
+0.5 (+1.16%)
1SHL gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 60 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of 1SHL while its profitability can be described as average. 1SHL has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
1SHL had positive earnings in the past year.
1SHL had a positive operating cash flow in the past year.
Each year in the past 5 years 1SHL has been profitable.
1SHL had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a decent Return On Assets value of 4.87%, 1SHL is doing good in the industry, outperforming 66.67% of the companies in the same industry.
1SHL has a better Return On Equity (12.29%) than 73.33% of its industry peers.
The Return On Invested Capital of 1SHL (7.89%) is better than 70.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 1SHL is below the industry average of 8.99%.
The last Return On Invested Capital (7.89%) for 1SHL is above the 3 year average (5.87%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.87% | ||
| ROE | 12.29% | ||
| ROIC | 7.89% |
ROA(3y)3.87%
ROA(5y)4.27%
ROE(3y)9.76%
ROE(5y)10.27%
ROIC(3y)5.87%
ROIC(5y)6.49%
1.3 Margins
1SHL has a better Profit Margin (9.29%) than 66.67% of its industry peers.
In the last couple of years the Profit Margin of 1SHL has declined.
The Operating Margin of 1SHL (13.76%) is better than 65.00% of its industry peers.
In the last couple of years the Operating Margin of 1SHL has declined.
1SHL has a Gross Margin of 38.76%. This is in the lower half of the industry: 1SHL underperforms 76.67% of its industry peers.
In the last couple of years the Gross Margin of 1SHL has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.76% | ||
| PM (TTM) | 9.29% | ||
| GM | 38.76% |
OM growth 3Y-4.02%
OM growth 5Y-4.5%
PM growth 3Y-3.26%
PM growth 5Y-4.26%
GM growth 3Y-0.66%
GM growth 5Y-1.05%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 1SHL is creating some value.
Compared to 1 year ago, 1SHL has more shares outstanding
Compared to 5 years ago, 1SHL has more shares outstanding
1SHL has a better debt/assets ratio than last year.
2.2 Solvency
1SHL has an Altman-Z score of 1.99. This is not the best score and indicates that 1SHL is in the grey zone with still only limited risk for bankruptcy at the moment.
1SHL's Altman-Z score of 1.99 is in line compared to the rest of the industry. 1SHL outperforms 48.33% of its industry peers.
1SHL has a debt to FCF ratio of 5.10. This is a neutral value as 1SHL would need 5.10 years to pay back of all of its debts.
1SHL has a Debt to FCF ratio (5.10) which is in line with its industry peers.
1SHL has a Debt/Equity ratio of 0.66. This is a neutral value indicating 1SHL is somewhat dependend on debt financing.
1SHL has a Debt to Equity ratio of 0.66. This is in the lower half of the industry: 1SHL underperforms 73.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 5.1 | ||
| Altman-Z | 1.99 |
ROIC/WACC1.26
WACC6.26%
2.3 Liquidity
1SHL has a Current Ratio of 1.12. This is a normal value and indicates that 1SHL is financially healthy and should not expect problems in meeting its short term obligations.
1SHL has a worse Current ratio (1.12) than 70.00% of its industry peers.
1SHL has a Quick Ratio of 1.12. This is a bad value and indicates that 1SHL is not financially healthy enough and could expect problems in meeting its short term obligations.
1SHL's Quick ratio of 0.77 is on the low side compared to the rest of the industry. 1SHL is outperformed by 73.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.12 | ||
| Quick Ratio | 0.77 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 11.21% over the past year.
The Earnings Per Share has been growing slightly by 7.27% on average over the past years.
Looking at the last year, 1SHL shows a small growth in Revenue. The Revenue has grown by 5.85% in the last year.
The Revenue has been growing by 9.02% on average over the past years. This is quite good.
EPS 1Y (TTM)11.21%
EPS 3Y3.35%
EPS 5Y7.27%
EPS Q2Q%23.08%
Revenue 1Y (TTM)5.85%
Revenue growth 3Y7.51%
Revenue growth 5Y9.02%
Sales Q2Q%4.41%
3.2 Future
The Earnings Per Share is expected to grow by 9.71% on average over the next years. This is quite good.
The Revenue is expected to grow by 5.62% on average over the next years.
EPS Next Y9.68%
EPS Next 2Y8.26%
EPS Next 3Y9.53%
EPS Next 5Y9.71%
Revenue Next Year4.89%
Revenue Next 2Y4.63%
Revenue Next 3Y5.08%
Revenue Next 5Y5.62%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 18.38, 1SHL is valued on the expensive side.
78.33% of the companies in the same industry are more expensive than 1SHL, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 25.47, 1SHL is valued a bit cheaper.
Based on the Price/Forward Earnings ratio of 16.74, the valuation of 1SHL can be described as correct.
1SHL's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. 1SHL is cheaper than 66.67% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.42, 1SHL is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.38 | ||
| Fwd PE | 16.74 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1SHL indicates a somewhat cheap valuation: 1SHL is cheaper than 63.33% of the companies listed in the same industry.
86.67% of the companies in the same industry are more expensive than 1SHL, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.04 | ||
| EV/EBITDA | 13.71 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
1SHL has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.9
PEG (5Y)2.53
EPS Next 2Y8.26%
EPS Next 3Y9.53%
5. Dividend
5.1 Amount
1SHL has a Yearly Dividend Yield of 1.96%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.11, 1SHL pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.44, 1SHL has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.96% |
5.2 History
On average, the dividend of 1SHL grows each year by 6.35%, which is quite nice.
Dividend Growth(5Y)6.35%
Div Incr YearsN/A
Div Non Decr YearsN/A
5.3 Sustainability
49.08% of the earnings are spent on dividend by 1SHL. This is a bit on the high side, but may be sustainable.
1SHL's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP49.08%
EPS Next 2Y8.26%
EPS Next 3Y9.53%
BIT:1SHL (11/14/2025, 7:00:00 PM)
43.74
+0.5 (+1.16%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners12.27%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap49.34B
Revenue(TTM)23.38B
Net Income(TTM)2.17B
Analysts83.7
Price Target61.96 (41.66%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.96% |
Yearly Dividend0.95
Dividend Growth(5Y)6.35%
DP49.08%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.66%
Min EPS beat(2)-2.04%
Max EPS beat(2)13.36%
EPS beat(4)3
Avg EPS beat(4)5.82%
Min EPS beat(4)-2.04%
Max EPS beat(4)13.36%
EPS beat(8)5
Avg EPS beat(8)3.25%
EPS beat(12)8
Avg EPS beat(12)3.67%
EPS beat(16)10
Avg EPS beat(16)2.87%
Revenue beat(2)1
Avg Revenue beat(2)-0.25%
Min Revenue beat(2)-0.77%
Max Revenue beat(2)0.27%
Revenue beat(4)2
Avg Revenue beat(4)-0.01%
Min Revenue beat(4)-0.81%
Max Revenue beat(4)1.29%
Revenue beat(8)3
Avg Revenue beat(8)-0.4%
Revenue beat(12)4
Avg Revenue beat(12)-0.45%
Revenue beat(16)8
Avg Revenue beat(16)0.12%
PT rev (1m)0.36%
PT rev (3m)-0.49%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-16.03%
EPS NY rev (1m)0.1%
EPS NY rev (3m)-2.25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.82%
Revenue NY rev (1m)-0.05%
Revenue NY rev (3m)-0.76%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.38 | ||
| Fwd PE | 16.74 | ||
| P/S | 2.11 | ||
| P/FCF | 16.04 | ||
| P/OCF | 12.83 | ||
| P/B | 2.79 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.71 |
EPS(TTM)2.38
EY5.44%
EPS(NY)2.61
Fwd EY5.98%
FCF(TTM)2.73
FCFY6.23%
OCF(TTM)3.41
OCFY7.8%
SpS20.73
BVpS15.67
TBVpS-5.42
PEG (NY)1.9
PEG (5Y)2.53
Graham Number28.97
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.87% | ||
| ROE | 12.29% | ||
| ROCE | 10.07% | ||
| ROIC | 7.89% | ||
| ROICexc | 8.64% | ||
| ROICexgc | 46.76% | ||
| OM | 13.76% | ||
| PM (TTM) | 9.29% | ||
| GM | 38.76% | ||
| FCFM | 13.16% |
ROA(3y)3.87%
ROA(5y)4.27%
ROE(3y)9.76%
ROE(5y)10.27%
ROIC(3y)5.87%
ROIC(5y)6.49%
ROICexc(3y)6.25%
ROICexc(5y)6.86%
ROICexgc(3y)30.57%
ROICexgc(5y)31.67%
ROCE(3y)7.49%
ROCE(5y)8.29%
ROICexgc growth 3Y-8.79%
ROICexgc growth 5Y-3.88%
ROICexc growth 3Y1.69%
ROICexc growth 5Y-10.54%
OM growth 3Y-4.02%
OM growth 5Y-4.5%
PM growth 3Y-3.26%
PM growth 5Y-4.26%
GM growth 3Y-0.66%
GM growth 5Y-1.05%
F-Score8
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 5.1 | ||
| Debt/EBITDA | 2.58 | ||
| Cap/Depr | 59.37% | ||
| Cap/Sales | 3.29% | ||
| Interest Coverage | 7.09 | ||
| Cash Conversion | 85.2% | ||
| Profit Quality | 141.62% | ||
| Current Ratio | 1.12 | ||
| Quick Ratio | 0.77 | ||
| Altman-Z | 1.99 |
F-Score8
WACC6.26%
ROIC/WACC1.26
Cap/Depr(3y)58.06%
Cap/Depr(5y)61.48%
Cap/Sales(3y)3.63%
Cap/Sales(5y)3.7%
Profit Quality(3y)91.88%
Profit Quality(5y)100.74%
High Growth Momentum
Growth
EPS 1Y (TTM)11.21%
EPS 3Y3.35%
EPS 5Y7.27%
EPS Q2Q%23.08%
EPS Next Y9.68%
EPS Next 2Y8.26%
EPS Next 3Y9.53%
EPS Next 5Y9.71%
Revenue 1Y (TTM)5.85%
Revenue growth 3Y7.51%
Revenue growth 5Y9.02%
Sales Q2Q%4.41%
Revenue Next Year4.89%
Revenue Next 2Y4.63%
Revenue Next 3Y5.08%
Revenue Next 5Y5.62%
EBIT growth 1Y18.19%
EBIT growth 3Y3.18%
EBIT growth 5Y4.12%
EBIT Next Year49.21%
EBIT Next 3Y20.47%
EBIT Next 5Y15.42%
FCF growth 1Y161.12%
FCF growth 3Y-1.94%
FCF growth 5Y15.48%
OCF growth 1Y86.79%
OCF growth 3Y-1.23%
OCF growth 5Y11.83%
SIEMENS HEALTHINEERS AG / 1SHL.MI FAQ
What is the ChartMill fundamental rating of SIEMENS HEALTHINEERS AG (1SHL.MI) stock?
ChartMill assigns a fundamental rating of 5 / 10 to 1SHL.MI.
What is the valuation status for 1SHL stock?
ChartMill assigns a valuation rating of 5 / 10 to SIEMENS HEALTHINEERS AG (1SHL.MI). This can be considered as Fairly Valued.
How profitable is SIEMENS HEALTHINEERS AG (1SHL.MI) stock?
SIEMENS HEALTHINEERS AG (1SHL.MI) has a profitability rating of 6 / 10.
What is the financial health of SIEMENS HEALTHINEERS AG (1SHL.MI) stock?
The financial health rating of SIEMENS HEALTHINEERS AG (1SHL.MI) is 3 / 10.
What is the earnings growth outlook for SIEMENS HEALTHINEERS AG?
The Earnings per Share (EPS) of SIEMENS HEALTHINEERS AG (1SHL.MI) is expected to grow by 9.68% in the next year.